GlassScriptPhysician profile
Hermann P Kessler
NPI 1417299363
$9,928.04
in general payments reported to CMS, 2019-2025
18 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 75% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $940 · 2020: $1,485 · 2021: $2,500 · 2022: $626 · 2023: $2,104 · 2024: $1,027 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,327 · Consulting Fee: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,327.25 |
| Consulting Fee | $1,050.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,790.37 | 2021-2023 | Ligasure |
| Aroa Biosurgery Incorporated | $2,223.22 | 2022-2025 | |
| Heron Therapeutics, INC. | $1,400.00 | 2020 | |
| Ethicon US, LLC | $887.32 | 2020-2025 | Echelon Circular, Contour, Enseal |
| Covidien LP | $504.54 | 2019 | |
| Kerecis Limited | $384.37 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Baxter Healthcare | $369.96 | 2022-2024 | Tisseel, Hillrom - Fcs 700 Boom |
| Dilon Technologies, INC. | $233.48 | 2025 | Hemoblast Bellows |
| Mimedx Group, INC. | $220.30 | 2025 | |
| Davol INC. | $136.89 | 2024 | Arista Ah Flexitip |
| Prescient Surgical | $133.76 | 2019 | |
| Solventum Corporation | $126.94 | 2024 | Prevena, V.A.C.Ulta |
| Pacira Pharmaceuticals Incorporated | $121.34 | 2019 | |
| Ferring Pharmaceuticals INC. | $120.76 | 2019 | |
| Intuitive Surgical, INC. | $113.15 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $75.81 | 2024 | Spyglass Discover |
| Conmed Corporation | $59.95 | 2019 | |
| Guard Medical INC. | $25.88 | 2025 | Npseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hermann Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.